NIH-funded research R01 grant

Integrative multi-omics to understand diabetic retinopathy

Official title: Integrative multi-omics for discovery of molecular pathways associated with diabetic retinopathy

Funded at University of Michigan at Ann Arbor · NIH-11514593 · Data updated 2026-11-12

A doctor-scientist team will study blood markers and genetic signals to see why diabetic retinopathy happens and how it affects Hispanic/Latino people.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Michigan at Ann Arbor
NIH-funded
Lab location1 site (Ann Arbor, United States)
Project startMarch 16, 2026
Project endApril 30, 2029
Funding year2026
Award (this year)$736,801
NIH project number7R01EY036258-03
Project IDNIH-11514593 on NIH RePORTER

Who could benefit from this research

Could help

Adults with type 2 diabetes, especially within Hispanic/Latino communities, who have or are at risk of diabetic retinopathy and consent to blood sampling and genetic/metabolomic analysis.

Less likely to help

Individuals without diabetes or with advanced, non-replicable retinopathy may not directly benefit from this study.

What this research studies

This project looks at how genes and tiny molecules in blood relate to diabetic retinopathy, a leading cause of blindness in people with diabetes. Researchers will analyze transcript and metabolite levels in a Hispanic cohort with and without retinopathy, then try to replicate findings in another group. The aim is to connect genomic data to disease mechanisms and to identify signatures that could guide future treatments or prevention. The study emphasizes representation of Hispanic/Latino individuals who carry a high burden of disease and will use blood samples and clinical information to link biology to eye health.

Why it matters

Potential benefit: If successful, the work could reveal blood markers and biological pathways that help predict, prevent, or treat diabetic retinopathy, especially in high-risk Hispanic/Latino populations.

How similar studies have gone: Earlier work has identified biomarkers and genes linked to retinopathy, but this study aims to connect them to mechanisms and increase representation in analyses.

Where this research is happening

  • University of Michigan at Ann Arbor
    Ann Arbor, United States
    Active

Researchers

  • Principal investigator: Padovani-Claudio, Dolly Ann — University of Michigan at Ann Arbor
  • Study coordinator: Padovani-Claudio, Dolly Ann

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.